Reviews emergency room use of two antiplatelet drugs for acute coronary syndrome
Reviews patient records of heart attack-type chest pain treated with two blood-thinning drugs.
Plain-language title generated from the registry record
Registry title: Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Key facts
- Where
- Amman, JordanSee the 2 sites
Where in Jordan
- Istishari HospitalAmman, JordanNot yet recruiting
- Jordan University HospitalAmman, JordanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jordan Collaborating Cardiology Group
- Trial code
- NCT07039149
- Record updated
- 28 November 2025
- Original description
This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?Read full original descriptionShow less
Dual Antiplatelet Agents Therapy in the Emergency Department for Acute Coronary Syndrome (The DATES Study).
This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?
Inclusion: Adult patients; Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina); Antiplatelet medication (s) prescribed during index admission to hospital; Willingness of the patient to be called for follow up up to 1 year after index hospitalization.
Exclusion: Non cardiac chest pain; No administration of antiplatelet agents during hospitalization; Refusal of contact for follow up.